Programmed cell death 1 (PD-1) and programmed death-ligand 1 (PD-L1) are the most extensively studied and recognized inhibitory checkpoint pathways, and their interaction induces the activation of the host immune system through T cell responses, thereby resulting in immune escape of tumor cells [53,54]. Here, PDCD1 is linked to neoplasm.